Climaco John M 4
4 · CNS Pharmaceuticals, Inc. · Filed Feb 6, 2024
Insider Transaction Report
Form 4
Climaco John M
DirectorChief Executive Officer
Transactions
- Award
Series B Warrant to purchase common stock
2024-02-01+166,666→ 393,533 totalExercise: $0.30From: 2024-02-01Exp: 2025-10-01→ Common Stock (166,666 underlying) - Award
Series A Warrant to purchase common stock
2024-02-01+166,666→ 226,867 totalExercise: $0.30From: 2024-02-01Exp: 2029-02-01→ Common Stock (166,666 underlying) - Purchase
Common stock
2024-02-01$0.30/sh+166,666$50,000→ 215,676 total
Footnotes (1)
- [F1]The common stock, Series A warrants and Series B warrants were acquired by the reporting person in a public offering conducted by the Company that was closed on February 1, 2024.